1) OR: Odds Ratio derived from logistic regression considering as cases patients whose biopsy Gleason score was lower than the prostatectomy Gleason score and as controls everybody else ...
Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting
Data highlights PYLARIFY’s ability to detect recurrent prostate cancer in patients with low PSAReal-world evidence of PYLARIFY’s effectiveness in ...
Salvage High-Intensity Focused Ultrasound For Locally Recurrent Prostate Cancer after Low-Dose-Rate Brachytherapy: Oncologic and Functional Outcomes According to the EAU-ESTRO-SIOG 2018 guidelines, ...
(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, TX was host to a prostate cancer poster session ... Patients in the bone group had a higher median Gleason ...
Untreated prostate cancer can sometimes cause erectile dysfunction (ED). However, ED is more commonly associated with ...
Background: In this population-based study, we investigated the degree of concordance between Gleason scores obtained ... for this study all 371 prostate cancer patients recorded at the Geneva ...
A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...
A study by UC San Francisco (UCSF) included nearly 388,000 men who had prostate cancer between 2004 and 2021. The incidence rate of cases increased 6.7% per year on average between 2011 and 2021 ...
6d
healthday on MSNImprovements in Prostate Cancer Mortality Plateaued From 2012 to 2021Distant-stage prostate cancer increased and mortality rates plateaued throughout California during the 2010s, accordin ...
Advanced prostate cancer cases are rising sharply in California, outpacing national trends, according to a new study from ...
Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results